Results 31 to 40 of about 14,748 (188)
Arrhythmogenic right ventricular dysplasia / cardiomyopathy (ARVD / C) is a rare genetic cardiomyopathy characterized by fibro-fatty replacement primarily of the right ventricular myocytes,and can present as any of 'concealed' disease, 'overt arrhythmia'
Varun Suresh
doaj +1 more source
Etiopathogenesis of arrhythmogenic right ventricular cardiomyopathy [PDF]
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is characterised by progressive fibro-fatty replacement of right ventricular myocardium. Earlier studies described ARVC as non-inflammatory, non-coronary disorder associated with arrhythmias, heart failure and sudden death due to functional exclusion of the right ventricle.
Maithili V N, Dokuparti +4 more
openaire +2 more sources
Background It has been suggested that endocardial and epicardial ablation of ventricular tachycardia (VT) improves outcome in arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Shibu Mathew +18 more
doaj +1 more source
Physical exercise and arrhythmogenic right ventricular cardiomyopathy/dysplasia: An overview
Arrhythmogenic right ventricular cardiomyopathy/dysplasia is inherited cardiomyopathy that has a propensity for ventricular arrhythmia, ventricular dysfunction, and sudden cardiac death.
Rasha Kaddoura, Hassan Al-Tamimi
doaj +1 more source
Arrhythmogenic potential of cardiomyopathies
The article presents a review of literary scientific sources from the MEDLINE database on PubMed, Web of Science, Scopus, and Google Scholar platforms, focusing on arrhythmia in patients with arrhythmogenic cardiomyopathy.
O.M. Kovalova +5 more
doaj +1 more source
Treatment of arrhythmogenic right ventricular cardiomyopathy (dysplasia) [PDF]
Arrhythmogenic right ventricular cardiomyopathy (dysplasia) is an inheritable heart muscle disease predisposing to ventricular arrhythmias and increasing risk of sudden cardiac death.
M.Т. Vatutin +5 more
doaj
Background Arrhythmogenic cardiomyopathy (AC) is characterized by biventricular dysfunction, exercise intolerance, and high risk of ventricular tachyarrhythmias and sudden death.
Øyvind H. Lie +8 more
doaj +1 more source
Management of arrhythmogenic right ventricular cardiomyopathy
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a disease characterised by fibrofatty replacement of the ventricular myocardium due to specific mutations, leading to ventricular arrhythmias and sudden cardiac death. Treating this condition can be challenging due to progressive fibrosis, phenotypic variations and small patient cohorts limiting
Sayed Al-Aidarous +3 more
openaire +3 more sources
Disulfide Bond–Modified Proteomics Reveals the Effects of Riboflavin on Protein Folding Dynamics
Riboflavin deficiency impairs oxidative protein folding, causing ER misfolded protein accumulation, CHOP activation, and apoptosis, revealing a role of riboflavin in proteostasis. ABSTRACT Riboflavin is a crucial micronutrient essential for maintaining cellular homeostasis, acting as an important precursor for flavoproteins that utilize flavin ...
Bo Zhang, Shuisheng Hou, Jing Tang
wiley +1 more source
Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo +7 more
wiley +1 more source

